Kris Kieswetter
Global Senior Director, Applied Medical Sciences3MIbraheem Badejo
Senior R&D Director, External Front End InnovationJohnson & JohnsonIbraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.
From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.
During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.
Ib received his BA degree in chemistry from Avila University. He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending
Elizabeth Hamacher
Vice President, Clinical Services and SupportPodimetricsElizabeth is a solutions-driven health care executive with demonstrated success in leading both clinical and administrative growth across multiple health care settings. As Vice President of Care Management, she is responsible for scaling Podimetrics’ work to efficiently and effectively serve more patients. Elizabeth has held clinical leadership roles at Consumer Medical, Beth Israel Lahey Health, Coastal Medical, Cape Cod Healthcare Physician Hospital Organization, and Emerald Physician Services LLC, leading strategic planning, leadership development, operations, and quality improvement efforts. She holds a Master’s degree in Healthcare Leadership from Brown University, a Bachelor of Science in nursing from Massachusetts General Hospital Institute of Health Professions, and a Bachelor of Science in Mathematical Sciences from Worcester Polytechnic Institute.
Julie Morabito
Assistant DirectorFDAAssistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).
Monique Rennie
Global Director, Medical Affairs, Wound CareMölnlyckeIra Herman
Senior Director, Biological SciencesPrecision HealingKatherine Piette
Chief Executive OfficerCorstrataMike Griffiths
Chief Executive Officer & Medical DirectorAdvanced Oxygen TherapyMitch Sanders
Chief Executive OfficerProDevLabsDavide Vigano
Co-founder and CEOSensoria HealthSensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line. He acted as Vice President of the Worldwide SMSP Medium Business division which he grew 18% YOY to over $14B. Davide also managed the Italian Marketing, Business and Enterprise operations for five years and brought it to number one in the world for contribution margin, 6th largest Microsoft subsidiary in the world by revenues.
Parth Desai
PrincipalFlare Capital PartnersChris Rao
SVP Clinical OperationsAlira HealthThomas Serena
Founder & CEOSerenaGroupDr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.
To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.
He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.
Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.
Nikolai Sopko
Chief Scientific Officer and VP of R&DPolarityTE, Inc.Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr. Sopko is currently the Chief Scientific Officer and Vice President of Research and Development of PolarityTE where he applies his passion for patient care and basic science
Kenny Carberry
Vice President of Business DevelopmentAlira HealthKenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.
David Alper
Board AdviserAmerican Diabetes Association Amputation Prevention AllianceJens Kirsch
Chief Executive OfficerTerraplasma Medical GMBHWindy Cole
Global Medical Affairs DirectorNATROX® Wound CareAnthony Kerr
Managing DirectorJournal of Wound CareTim Ganey
Chief Scientific OfficerVIVEX BiologicsDan King
Director of MarketingPolynovoMelissa Bailey
VP of Sales & MarketingSwift MedicalAlan Sage
Chief Executive OfficerVaparoxArnie Andersen
VP of Post Acute CareGentellJavier Guirola
Director of Medical AffairsPolynovoSusan Paquette
Vice President and General Manager, WoundSmartTRAKMary McGovern
Managing DirectorAdtec Healthcare LimitedKyle Quinn
Associate ProfessorUniversity of ArkansasSameer Sonkusale
ProfessorTufts UniversityMolly Carroll
Senior ScientistPrecision Healing